|
Press Releases |
|
|
|
Tuesday, August 10, 2021 |
|
冠科美博(APOLLOMICS)APL-102 中国I期临床研究完成首例患者给药 |
冠科美博( Apollomics Inc.),一家致力于发现和开发肿瘤靶向和免疫新药及其组合疗法的创新生物制药公司,今天宣布,APL-102已经成功完成首例患者给药。 more info >> |
|
冠科美博(APOLLOMICS)APL-102 中國I期臨床研究完成首例患者給藥 |
冠科美博( Apollomics Inc.),一家致力於發現和開發腫瘤靶向和免疫新藥及其組合療法的創新生物製藥公司,今天宣佈,APL-102已經成功完成首例患者給藥。 more info >> |
|
Apollomics, Inc. Doses First Patient in a Phase I Clinical Trial of APL-102 |
Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination oncology therapies, today announced the successful dosing of the first patient in a Phase I clinical study of APL-102 in patients with advanced solid tumors. more info >> |
|
Thursday, May 20, 2021 |
|
冠科美博上海分公司正式开业 |
Apollomics, Inc. (冠科美博),一家致力于发现和开发肿瘤靶向和免疫新药及其组合疗法的创新生物制药公司,今天宣布, 冠科美博上海分公司正式开业并启用,地址位于上海市浦东张江高科技园区。 more info >> |
|
冠科美博上海分公司正式開業 |
Apollomics, Inc. (冠科美博),一家致力於發現和開發腫瘤靶向和免疫新藥及其組合療法的創新生物製藥公司,今天宣佈, 冠科美博上海分公司正式開業並啟用,地址位於上海市浦東張江高科技園區。 more info >> |
|
APOLLOMICS INC. ANNOUNCES OFFICIAL OPENING OF SHANGHAI BRANCH |
Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that Apollomics Shanghai Branch has been officially opened and started its operations at Zhangjiang Hi-Tech Park, Pudong District, Shanghai. more info >> |
|
Tuesday, March 9, 2021 |
|
APOLLOMICS(冠科美博)任命K. PEONY YU余健鸿医学博士为首席医学官(CMO) |
Apollomics, Inc.(冠科美博),一家致力于发现和开发肿瘤靶向和免疫新药及其组合疗法的创新生物制药公司,今天宣布,任命K. PEONY YU(余健鸿)医学博士为首席医学官,余博士将于2021年3月16日正式上任。 more info >> |
|
APOLLOMICS(冠科美博)任命K. PEONY YU余健鴻醫學博士為首席醫學官(CMO) |
Apollomics, Inc.(冠科美博),一家致力於發現和開發腫瘤靶向和免疫新藥及其組合療法的創新生物製藥公司,今天宣佈,任命K. PEONY YU(余健鴻)醫學博士為首席醫學官,余博士將于2021年3月16日正式上任。 more info >> |
|
Wednesday, February 3, 2021 |
|
两个移民,一项独特的生物制药创业计划 |
“美国梦就是,不论社会阶层还是出身背景,每个人都应该有机会凭借其能力与取得的成就获得更美好、更富足、更充实的生活。” -- James Truslow Adams more info >> |
|
Tuesday, March 9, 2021 |
|
Apollomics, Inc. Appoints Seasoned Healthcare Executive K. Peony Yu, M.D., as Chief Medical Officer |
Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced the appointment of K. Peony Yu, M.D. as Chief Medical Officer. Dr. Yu will assume the role on March 16, 2021. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
和泓服务:深耕西南区域,业绩稳健增长
Mar 29, 2024 21:43 HKT/SGT
|
|
|
乐普生物2023年收入快速增长,亏损大幅收窄,ADC进入收获期
Mar 29, 2024 19:48 HKT/SGT
|
|
|
樂普生物2023年收入快速增長,虧損大幅收窄,ADC進入收穫期
Mar 29, 2024 19:41 HKT/SGT
|
|
|
海通恒信业绩出炉:切实服务实体经济发展 经营质效稳步提升
Mar 29, 2024 18:56 HKT/SGT
|
|
|
海通恒信業績出爐:切實服務實體經濟發展 經營質效穩步提升
Mar 29, 2024 18:52 HKT/SGT
|
|
|
和泓服务:深耕西南区域,业绩稳健增长
Mar 29, 2024 18:43 HKT/SGT
|
|
|
和泓服務:深耕西南區域,業績穩健增長
Mar 29, 2024 18:31 HKT/SGT
|
|
|
MHI Concludes Positive Impact Finance Agreement
Mar 29, 2024 19:20 JST
|
|
|
锅圈:持续扩大业务规模 盈利能力持续增强
Mar 29, 2024 18:10 HKT/SGT
|
|
|
Atlas Lithium Secures US$ 30,000,000 Strategic Investment and Offtake Agreement from Mitsui
Mar 29, 2024 18:09 HKT/SGT
|
|
|
鍋圈:持續擴大業務規模 盈利能力持續增強
Mar 29, 2024 18:07 HKT/SGT
|
|
|
Guoquan: Continuously Expanding the Business Scale While Enhancing Profitability
Mar 29, 2024 18:02 HKT/SGT
|
|
|
直面企业发展转型挑战 联想控股如何发展新质生产力
Mar 29, 2024 17:14 HKT/SGT
|
|
|
直面企業發展轉型挑戰 聯想控股如何發展新質生產力
Mar 29, 2024 17:10 HKT/SGT
|
|
|
联想控股2023年收入4360亿元
Mar 29, 2024 17:05 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|